When Merck yanked Vioxx, investors at first thought Pfizer (nyse: PFE - news - people ), which made rival drugs Celebrex and Bextra, would profit.

FORBES: For Merck, A New Worry Amid Success

He was fiercely angry, yeah, and at first I thought it was the normal upset after a break-up maybe some people take it differently.

BBC: [an error occurred while processing this directive]